"A study of 153 adults with a body mass index of 30 or higher who were current alcohol drinkers and used a GLP-1 drug found significant reductions in self-reported alcohol intake, binge drinking, and lower scores on alcohol use disorder tests."
"A large, 17-year observational study in Sweden indicated that among problem drinkers with both obesity and Type 2 diabetes, GLP-1 drugs substantially decreased the risk for hospitalizations related to alcohol use disorder."
"Drs. Bianca Robertson and Jonathan Vargas from UCLA emphasized the potential of GLP-1 and related drugs to treat alcoholism and possibly other substance use disorders."
"Alcohol-related diseases kill about 178,000 Americans every year, showing a clear need for more effective medical interventions, as GLP-1 drugs offer a promising solution."
GLP-1 drugs, initially designed for diabetes management and weight loss, are emerging as a potential treatment for alcoholism and substance use disorders. With over 178,000 alcohol-related deaths annually, their medical intervention could prove crucial. Recent studies show that GLP-1 drugs substantially lower self-reported alcohol intake, binge drinking, and related hospitalizations among individuals with obesity and alcohol use disorder. Specialists from UCLA indicate this is a significant development in addiction treatment, with further studies anticipated to explore these drugs' broader applications in addressing substance use issues.
Read at The Mercury News
Unable to calculate read time
Collection
[
|
...
]